CALDISA LIMITED
Company number 13826259 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
CALDISA LIMITED - Analysis Report
Company Number: 13826259
Analysis Date: 2025-07-20 12:34 UTC
Financial Health Assessment for CALDISA LIMITED
1. Financial Health Score: B
Explanation:
CALDISA LIMITED demonstrates a solid financial footing for a micro-entity at its early stage of operations since incorporation in 2022. The company shows strong liquidity and positive net assets with steady growth year-on-year. While profitability data is not explicitly provided, the robust working capital and equity base indicate a generally healthy financial condition. The "B" grade reflects good financial health with room for continued monitoring and growth, particularly as the company scales.
2. Key Vital Signs
| Metric | 2024 Figure (£) | Interpretation |
|---|---|---|
| Fixed Assets | 3,568 | Presence of some long-term assets indicates investment in business infrastructure. |
| Current Assets | 48,942 | Healthy cash or receivables supporting operational needs. |
| Current Liabilities | 3,451 | Low short-term debt indicating manageable immediate obligations. |
| Net Current Assets | 45,491 | Strong working capital, a sign of liquidity and operational stability. |
| Total Assets Less Current Liabilities | 49,059 | Indicates positive net assets, showing the company’s financial buffer. |
| Shareholders’ Funds | 49,059 | Equity capital is growing, reflecting retained earnings or investment. |
| Average Number of Employees | 2 | Small team consistent with a micro-entity status. |
| Filing Status | Up to date | Compliance with filing deadlines signals good governance. |
Additional Notes:
- Net current assets have increased nearly fourfold from £11,459 in 2023 to £45,491 in 2024, a very positive sign of improved liquidity and operational cash flow health.
- The increase in fixed assets from nil to £3,568 indicates asset acquisition, possibly equipment or small property enhancements, which may support growth.
3. Diagnosis: What the Financial Data Reveals About Business Health
CALDISA LIMITED is in the early stages of its lifecycle but presents no symptoms of financial distress. Its vital signs resemble a "healthy pulse" with strong liquidity and a growing equity base, akin to a patient with good circulation and no signs of infection or inflammation. The company is managing its short-term liabilities well, ensuring it can meet immediate obligations without stress.
The significant increase in current assets and net current assets signals that the company is generating or receiving considerable cash or receivables, which supports ongoing operations smoothly. The balance sheet shows positive net assets—equivalent to a strong "immune system"—providing resilience against unexpected financial shocks.
However, the company’s small scale (micro-entity) means it faces typical early-stage risks such as limited diversification and dependency on key individuals (noted PSCs). The low employee count and absence of audit indicate a lean operation, which is common but requires vigilance to maintain controls as the company grows.
4. Recommendations: Specific Actions to Improve Financial Wellness
- Maintain Strong Cash Flow Management: Continue monitoring receivables and payables to preserve liquidity. Avoid overextending credit to customers to prevent cash flow "blockages."
- Plan for Asset Utilization: Review the fixed assets acquired to ensure they contribute effectively to revenue generation or efficiency improvements. Avoid unnecessary capital expenditure that could strain cash resources.
- Build Profitability Metrics: Although equity is growing, tracking profit and loss is crucial. Implement regular P&L monitoring to detect early warning signs of margin compression or cost overruns.
- Strengthen Internal Controls: As the company grows, implement controls for financial reporting and compliance to avoid operational risks that small companies may overlook.
- Explore Growth Opportunities Cautiously: Leverage the strong balance sheet to consider measured expansion or investment, but avoid over-leveraging which could introduce symptoms of financial stress.
- Maintain Compliance Vigilance: Keep filing accounts and confirmation statements timely to prevent penalties and preserve reputation.
- Succession and Key Person Risk Planning: With two PSCs holding significant control, consider plans to mitigate risks associated with key personnel changes.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.